Mitsunori Higuchi
Fukushima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Immunolocalization of CD28, CTLA-4 and CD80 in Non-Small Cell Lung Carcinoma: Combined CD28/CTLA-4/CD80 Status is a Potent Prognostic Factor of These Patients.
Journal: The Tohoku journal of experimental medicine
Published: June 18, 2025
Development of a novel artificial intelligence algorithm to detect pulmonary nodules on chest radiography.
Journal: Fukushima journal of medical science
Published: October 19, 2023
Salvage surgery for advanced non-small cell lung cancer following previous immunotherapy: a retrospective study.
Journal: Journal of cardiothoracic surgery
Published: March 08, 2023
Laparoscopic repair of an incarcerated inguinal hernia containing the sigmoid colon with a colonoscope.
Journal: Asian journal of endoscopic surgery
Published: January 14, 2023
Resistance Mechanisms to Immune Checkpoint Inhibitor and Its Overcome with Focus on β-Catenin in Lung Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: September 26, 2022
β-Catenin Expression in Non-Small Cell Lung Cancer and Therapeutic Effect of Immune Checkpoint Inhibitors
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: September 26, 2022
CTLA-4 Expression in Tumor-infiltrating Lymphocytes Is Irrelevant to PD-L1 Expression in NSCLC.
Journal: Anticancer research
Published: October 04, 2021
Immunolocalization of CD80 and CD86 in Non-Small Cell Lung Carcinoma: CD80 as a Potent Prognostic Factor.
Journal: Acta histochemica et cytochemica
Published: September 03, 2021
The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.
Journal: Cancer immunology, immunotherapy : CII
Published: May 19, 2021
Pathological Complete Response after Immune-Checkpoint Inhibitor Followed by Salvage Surgery for Clinical Stage IV Pulmonary Adenocarcinoma with Continuous Low Neutrophil-to-Lymphocyte Ratio: A Case Report.
Journal: Case reports in oncology
Published: February 22, 2021
Last Updated: 09/26/2026